People more likely to empathise with groups than individuals, study finds
People are more willing to empathise with groups of people rather than individuals, a study suggests.
Empathy – a person's ability to understand and share the feelings of another – is also viewed as 'distressing' when compared with remaining neutral, researchers said.
The study, led by scientists in Sweden and published in the journal Frontiers In Psychology, involved 296 people.
They underwent a test involving two blocks of pictures, one of individuals and the other of groups of people.
They were also presented with two decks of cards, one of which asked them to try to empathise and the other which asked them to remain neutral.
When given a picture to react to, the participants were asked to write down three keywords to describe the feelings of the people in the images or their appearance.
They were also asked to rate how much effort empathising took, or if they found the process distressing.
Researchers found people chose to stay objective to individuals compared with when they were faced with a group.
In both situations, empathising was also rated as distressing and more effort.
Dr Hajdi Moche, of Linkoping University in Sweden, said: 'People's willingness to empathise is different depending on who the target is: a single individual or a group of people.
'Specifically, people were more willing to empathise with a group than an individual, although empathising was rated as more effortful and distressing compared to staying objective – for both the individual and the group.'
When faced with images of an individual, people chose to empathise 34% of the time, researchers found.
However, during the block of group pictures, people empathised 53% of the time.
This happened even though empathising was rated as harder and more distressing than remaining objective.
Dr Moche added: 'The task of trying to share the internal experiences of the other requires more effort, imagination and understanding of what the person might feel compared to describing external features like hair colour.
'To share in the internal experiences might be especially hard when the information at hand is only a neutral facial expression without any body language or background context.'
Dr Moche suggested further studies could pit images of individuals and groups against each other to see which people would prefer to empathise with
'In this way, we would have a direct comparison in willingness to empathise when the target is an individual versus a group of people,' she added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
NHS to get up to £30 billion as other services squeezed in spending review
The NHS is set to be one of the big winners in next week's spending review – with a boost of up to £30 billion at the expense of other public services. The Department for Health and Social Care is set to get the biggest settlement in the government 's spending review next week, while other areas will face cuts. Chancellor Rachel Reeves will argue that Labour is investing in health, security and the economy, according to reports in The Times. The Department of Health is set to be handed a 2.8% annual increase in its day-to-day budget over a three-year period. This amounts to a cash increase of £30 billion by 2028 - £17 billion in real terms. However, the health services capital spending budget will only increase in line with inflation, according to the reports. Reeves will put £113 billion a year extra in infrastructure spending for projects designed to grow the economy, such as the Sizewell C nuclear power plant and a new generation of mini reactors. Bringing down NHS waiting times was one of Labour's key commitments. Sir Keir Starmer has pledged to ensure that by the next election 92% of patients in England waiting for planned treatment are seen within 18 weeks of being referred. Latest NHS data suggests around 60% of people are currently seen in this time and figures released last month showed the overall number of patients on waiting lists had risen slightly from 6.24 million to 6.25 million. Meanwhile, in order to meet tough financial savings targets this year and reduce the NHS its deficit by around £6.5 billion, hospital leaders have warned they're being forced to make cuts to frontline services. The NHS received £3.1 billion in additional capital investment in the 2024 budget, however, health leaders warned this was short of the £6.4 billion a year needed for the NHS to meet its productivity target of 2 per cent a year. A recent analysis by The Nuffield Trust shows that since coming into office, Labour has set healthcare spending to grow at 2.9 per cent for 2024-25 and 2025-26. Between 2011 and 2023-24, budgets grew at 2.4 per cent. For 2025-25, £1.5 billion of the additional funding for the NHS is due to cover the costs of the increase in employer National Insurance contributions, meaning for this financial year, spending growth will actually be less than 2 per cent, the Nuffield Trust estimates. Following the autumn budget, £22.6 billion extra was allocated to the DHSC however, this will be absorbed by spending pressures such as inflation and meeting waiting times targets. Matthew Taylor, chief executive of the NHS Confederation, told The Times that without big changes to the way the health service treats patients, the funding increase 'is not going to enable us to achieve recovery and reform'. 'Without additional capital investment, either traditional or through the private sector, I just don't think it's possible to combine recovery and reform,' he said.
Telegraph
an hour ago
- Telegraph
Art-eating fungus attacks Rome's ancient underground frescoes
A devastating infestation of microbugs is damaging the treasured underground frescoes that decorate the labyrinths of ancient catacombs beneath Rome. A vast network of tunnels, dug into the soft, porous tufa rock that underlies much of the city, was created in the early Christian era for the burial of the dead. They were also used as clandestine meeting places at a time when Christians were persecuted by Rome's emperors. But the colourful frescoes that adorn the ceilings and walls of the catacombs are being eaten away by microorganisms, a phenomenon that experts say is being accelerated by climate change. Rising temperatures have increased humidity levels inside the underground burial sites, encouraging the growth of bacteria, moss and fungus. The alarm about the rampant art-eating fungus has been raised by a Vatican department, the Pontifical Commission for Sacred Archaeology. 'The survival of frescoes which were created 2,000 years ago is at risk,' said Monsignor Pasquale Iacobone, the head of the department. 'There is an increase in the proliferation of vegetation, and the damage is unprecedented. It's the effect of climate change and the increase in outside temperatures.' Ancient Romans, who cremated their dead, banned Christians from burying corpses within the walls of the capital. So the Christians instead dug underground passageways for the interment of their dead, eventually excavating around 300 km of tunnels beneath Rome. They wrapped the dead in shrouds and laid them to rest in rectangular niches that were carved out of the tunnel walls. Among the treasures under threat are striking frescoes in the San Callisto Catacomb, which mark some of the earliest surviving examples of Christian art. San Callisto, the biggest and most famous of Rome's catacombs, was established in the second century AD and contained the remains of about half a million people, as well as seven popes who were martyred in the third century AD. 'Along with the six catacombs that are open to the public, the problem is affecting all 400 of the decorated chambers that exist in Rome's 60 catacombs. We are seeing an unexpected increase in biological infestations,' Barbara Mazzei, an archaeologist and an expert on the catacombs, told Corriere della Sera newspaper. While the problem underground is high humidity, the issue above ground is a lack of moisture – high temperatures and drought conditions mean that trees are sinking their roots deeper, breaking through the ceilings of the catacombs and penetrating the frescoes. The confined, subterranean nature of catacombs and the lack of ventilation mean that it is hard for experts to use chemicals such as biocides to combat the growth of bacteria and mould. Instead, they are experimenting with natural products that are not harmful to humans, including essential oils made from lavender, thyme and cinnamon. The threats faced by the catacombs were revealed at a seminar in Rome organised by the International Institute for Conservation of Historic and Artistic Works. Many of the catacombs lie beneath the Appian Way, the 'regina viarum' or 'queen of roads' that once ran from Rome to the distant port of Brindisi on the Adriatic coast. In 2010, the earliest known icons of four of Christ's apostles were discovered on the ceiling of an elaborately decorated chamber in a catacomb beneath the streets of Rome. Scientists used advanced laser technology to remove a hardened crust of dirt and calcium deposits to bring to light the brightly coloured fourth-century paintings of Saints John, Paul, Andrew and Peter. The images adorn the ceiling of a vault, carved out of volcanic rock, which provided the last resting place of a rich Roman noblewoman who converted to Christianity. Archaeologists also found an early image of Christ, a painting of a naked Daniel with lions at his feet and a sketch of Jesus raising Lazarus from the dead. The catacombs of Santa Tecla, a labyrinth of tunnels, galleries and burial chambers, lie hidden beneath a five-storey office in Ostiense, a residential area of Rome.
The Guardian
an hour ago
- The Guardian
Intrepid Geoff Thomas geared up for another crack at Tour de France route
When Geoff Thomas was forced to abandon his seventh attempt to complete Tour 21 at the age of 58 after an unforgiving day on the cobblestones, the former Crystal Palace captain thought his days in the saddle were over. 'My bike sort of disintegrated underneath me,' remembers Thomas. 'That's when the issues with my knees started so I'd not really been on the bike since then.' But, two years on and having celebrated his 60th birthday earlier this year, he will join the group of amateur riders in tackling the entire Tour de France route a week before the pros, a ride of nearly 3,500km to raise money for Cure Leukaemia. 'Before Christmas, it seemed a long shot because after so many years of playing football, I've got grade four arthritis in both my knees,' Thomas says. 'They said I was probably not far away from needing to have knee replacements. But I didn't really want to do that.' That was when Mark Gillett stepped in. The Premier League's chief medical officer took part in Tour 21 in 2022 when Thomas had to give up because of the chronic pain he was in. Gillett recommended a hydrogel injection called Arthrosamid, which was first developed for treating horses and is now being used for those suffering with osteoarthritis in the knee. 'You put the injection into the joint, and over three to six months, it gets incorporated into the joint lining and forms a physical barrier,' he says. 'So it's like a gel barrier, so that, whereas in arthritis the natural lining of the joint gets eroded and you get really sensitive nerve endings and bone on bone, you get that barrier between the two, so you're not feeling so much pain.' The results have been spectacular for Thomas, who jokes that 'it feels like polyfilla at times', adding: 'I could feel the knee not going through the same pain as it was when I was trying to get back on the bike. A couple of months later, I'm getting out there and doing 135-mile rides again. It's allowing me to have that dream of doing the Tour again.' Thomas, who won nine caps for England, knows all about overcoming the odds. He was given three months to live when he was diagnosed with chronic myeloid leukaemia in 2003, a year after retiring from playing. But, after receiving a stem cell transplant from his sister Kay and undergoing treatment from Prof Charlie Craddock, he entered remission in January 2005. The life-saving treatment motivated him to embark on his first Tour 21 a few months later to raise money for continuing research into the disease, with Thomas estimating that each edition has helped to raise more than £1m for Cure Leukaemia, which has also been adopted as the Tour de France's official charity partner. 'What the charity's done from when I was diagnosed in 2003 … the chances of any clinical trials going on in the world of blood cancer was minimal,' he says. 'It was Charlie who really had this vision of building an infrastructure that would accelerate trials through the system. That's up and running now and people are surviving in bigger numbers.' Thomas interrupted his training to see Palace finally lift their first major trophy by beating Manchester City – the club he supported as a child – at Wembley in the FA Cup final. It was 35 years after he had led them to their first final, before Palace finished third in the old First Division the following season. They were denied a place in Europe as English clubs were being phased back into European competition after being banned in the mid-1980s, and Thomas is hoping that the lure of a Europa League campaign under Oliver Glasner can persuade some of their best players such as Marc Guéhi and Eberechi Eze to stay in south London. 'Hopefully times are changing and Palace will be able to build on their success,' he says. But it is the prospect of completing this year's gruelling route – which will feature five mountain finishes including the famous Hautacam, Ventoux and the Col de la Loze summits – that will occupy his mind over the next few weeks. Gillett has full confidence that Thomas can overcome his knee issues and make it to the finish line on the Champs Élysées in mid-July. 'I'm a very optimistic guy, that's part of my job,' he says. 'But probably two or three months ago, I was thinking, 'I'm not sure he can do this'. But he's got a really good chance. He's done incredibly well.' For Thomas, finally completing the Tour for a seventh time would be a fitting way to round off his cycling career. 'In some ways, I wish I had finished in 2021 because it was fantastic riding into Paris knowing that we had raised so much money. But I knew I had to do it again and now I want to finish on a high to help celebrate Cure Leukaemia and what they are going to be doing over the next five to 10 years.' Support Geoff and the Tour 21 team in changing the future of treatment for blood cancer patients across the globe by donating to their Just Giving page.
